|Role of intratumoural heterogeneity in cancer drug resistance: molecular and clinical perspectives|
NA Saunders, F Simpson, EW Thompson, MM Hill, L Endo‐Munoz, ...
EMBO molecular medicine 4 (8), 675-684, 2012
|The role of osteoclasts and tumour-associated macrophages in osteosarcoma metastasis|
L Endo-Munoz, A Evdokiou, NA Saunders
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1826 (2), 434-442, 2012
|Phosphorylation of HIV Tat by PKR increases interaction with TAR RNA and enhances transcription|
L Endo-Munoz, T Warby, D Harrich, NAJ McMillan
Virology journal 2 (1), 1-13, 2005
|E2F7 can regulate proliferation, differentiation, and apoptotic responses in human keratinocytes: implications for cutaneous squamous cell carcinoma formation|
L Endo-Munoz, A Dahler, N Teakle, D Rickwood, M Hazar-Rethinam, ...
Cancer research 69 (5), 1800-1808, 2009
|Loss of osteoclasts contributes to development of osteosarcoma pulmonary metastases|
L Endo-Munoz, A Cumming, D Rickwood, D Wilson, C Cueva, C Ng, ...
Cancer research 70 (18), 7063-7072, 2010
|Preclinical evaluation of dual PI3K-mTOR inhibitors and histone deacetylase inhibitors in head and neck squamous cell carcinoma|
RB Erlich, Z Kherrouche, D Rickwood, L Endo-Munoz, S Cameron, ...
British Journal of Cancer 106 (1), 107-115, 2012
|Osteosarcoma is characterised by reduced expression of markers of osteoclastogenesis and antigen presentation compared with normal bone|
L Endo-Munoz, A Cumming, S Sommerville, I Dickinson, NA Saunders
British journal of cancer 103 (1), 73-81, 2010
|Dysregulation of the repressive H3K27 trimethylation mark in head and neck squamous cell carcinoma contributes to dysregulated squamous differentiation|
OM Gannon, LM de Long, L Endo-Munoz, M Hazar-Rethinam, ...
Clinical Cancer Research 19 (2), 428-441, 2013
|Stepwise pore size reduction of ordered nanoporous silica materials at angstrom precision|
S Jambhrunkar, M Yu, J Yang, J Zhang, A Shrotri, L Endo-Munoz, ...
Journal of the American Chemical Society 135 (23), 8444-8447, 2013
|Progression of osteosarcoma from a non-metastatic to a metastatic phenotype is causally associated with activation of an autocrine and paracrine uPA axis|
L Endo-Munoz, N Cai, A Cumming, R Macklin, L Merida de Long, ...
PLoS One 10 (8), e0133592, 2015
|Extracellular vesicles secreted by highly metastatic clonal variants of osteosarcoma preferentially localize to the lungs and induce metastatic behaviour in poorly metastatic …|
R Macklin, H Wang, D Loo, S Martin, A Cumming, N Cai, R Lane, ...
Oncotarget 7 (28), 43570, 2016
|Auranofin is a potent suppressor of osteosarcoma metastasis|
E Topkas, N Cai, A Cumming, M Hazar-Rethinam, OM Gannon, ...
Oncotarget 7 (1), 831, 2016
|A novel E2F/sphingosine kinase 1 axis regulates anthracycline response in squamous cell carcinoma|
M Hazar-Rethinam, LM de Long, OM Gannon, E Topkas, S Boros, ...
Clinical Cancer Research 21 (2), 417-427, 2015
|Tumor-initiating activity and tumor morphology of HNSCC is modulated by interactions between clonal variants within the tumor|
SR Cameron, AL Dahler, LB Endo-Munoz, I Jabbar, GP Thomas, PJ Leo, ...
Laboratory investigation 90 (11), 1594-1603, 2010
|Focal overexpression of CEACAM6 contributes to enhanced tumourigenesis in head and neck cancer via suppression of apoptosis|
S Cameron, LM de Long, M Hazar-Rethinam, E Topkas, L Endo-Munoz, ...
Molecular cancer 11 (1), 1-11, 2012
|The role of the E2F transcription factor family in UV-induced apoptosis|
M Hazar-Rethinam, L Endo-Munoz, O Gannon, N Saunders
International journal of molecular sciences 12 (12), 8947-8960, 2011
|Loss of E2F7 expression is an early event in squamous differentiation and causes derepression of the key differentiation activator Sp1|
M Hazar-Rethinam, SR Cameron, AL Dahler, LB Endo-Munoz, L Smith, ...
Journal of investigative dermatology 131 (5), 1077-1084, 2011
|A western blot to detect antibody to avian reovirus|
Avian pathology 19 (3), 477-487, 1990
|Results of a randomized, double-blind phase II clinical trial of NY-ESO-1 vaccine with ISCOMATRIX adjuvant versus ISCOMATRIX alone in participants with high-risk resected melanoma|
JS Cebon, M Gore, JF Thompson, ID Davis, GA McArthur, E Walpole, ...
Journal for immunotherapy of cancer 8 (1), 2020
|Merida de Long L., Topkas E., Mukhopadhyay P., Hill M., Saunders NA Progression of osteosarcoma from a non-metastatic to a metastatic phenotype is causally associated with …|
L Endo-Munoz, N Cai, A Cumming, R Macklin
PLoS One 10 (8), 2015